logo
Share SHARE
FONT-SIZE Plus   Neg

Cubist Pharma Q1 Profit Rises - Quick Facts

Cubist Pharmaceuticals, Inc. (CBST) Wednesday reported a higher profit for the first quarter as revenues increased 30 percent.

The Lexington, Massachusetts-based company reported a first-quarter net profit of $32.79 million or $0.45 per share, compared to $22.59 million or $0.34 per share last year.

Adjusted net income for the quarter rose to $66.31 million or $0.82 per share from $41.20 million or $0.54 per share in the prior-year quarter.

On average, 14 analysts polled by Thomson Reuters expected the company to earn $0.44 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter grew 30 percent to $211.69 million from $162.53 million in the prior-year quarter. Fourteen analysts had a consensus revenue estimate of $209.42 million for the quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
It is almost the end of the year. With the exception of a few, many of the biotech stocks, like the following, on which investors had bet big this year have served up only heartbreak. Now, let's take a look at some of the pending clinical trial catalysts of this month, which will make it a December to remember. Fast food major McDonald's is investing in $12,000 espresso machines for all of its U.S. restaurants, with a view to challenge Starbucks and Dunkin' Donuts in the coffee business, Bloomberg reported. Aiming to attract more customers, the company plans to reintroduce its coffee shop McCafe in 2017.. Retail giant Walmart has got high marks from an LBGT rights advocacy group for its LBTG friendly moves including insurance coverage for transgender workers this year. Human Rights Campaign or HRC, the largest advocacy group for lesbian, gay, bisexual and transgender rights, published its Corporate Equality Index, in which the discount retailer got a perfect 100 score.
comments powered by Disqus
Follow RTT